Solara Active Pharma Sciences Ltd ha announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received Certificate of Suitability approval for the manufacture of Ibuprofen API, from EDQM.
KEYTRUDA Is Now Approved in Combination With Chemotherapy as First-Line Treatment for Patients With Locally Recurrent Unresectable or Metastatic TNBC Whose Tumors Express PD-L1 and Who Have Not Received Prior Chemotherapy for Metastatic Disease KEYTRUDA Is the First Anti-PD-1 Therapy in Combination With Chemotherapy to Demonstrate Statistically Significant Overall Survival in These Patients; Based on Results From .
Tübinger Corona-Vakzin: Curevac-Zulassung steht auf der Kippe stuttgarter-zeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuttgarter-zeitung.de Daily Mail and Mail on Sunday newspapers.